Test Price
2,800 AED✅ Home Collection Available
TP63 Gene Limb-Mammary Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TP63 لمتلازمة الطرف والثدي (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | الملخص التنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
ضمان الدقة: حساسية تشخيصية بنسبة 99.9% من خلال معالجة معتمدة وفق ISO 9001:2015.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
خدمات لوجستية متميزة: جمع عينات منزلية بجودة المستشفيات عبر سلسلة تبريد معتمدة ISO وخدمة الفصد المتنقل VIP.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed experts.
إرشادات سريرية: استشارة هاتفية بعد الاختبار لتفسير النتائج مع خبراء مرخصين من هيئة الصحة بدبي.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
التأمين: التحقق من الفوترة المباشرة عبر واتساب +971 54 548 8731.
Overview
TP63 Gene Limb-Mammary Syndrome NGS Test detects pathogenic variants in the TP63 gene using high-depth Next-Generation Sequencing, confirming the molecular diagnosis of limb-mammary syndrome and related TP63-spectrum disorders. This test is essential for accurate genetic counseling, management planning, and early intervention in affected families. يكشف هذا الاختبار عن الطفرات الجينية في جين TP63 باستخدام تقنية التسلسل المتقدم NGS، مما يؤكد تشخيص متلازمة الطرف والثدي ويتيح الاستشارة الوراثية الدقيقة.
| Feature | Our Test (TP63 NGS) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | Targeted gene analysis with 100x mean depth > 99% sensitivity for coding region | Broad genomic coverage but lower depth (30-50x), may miss deep intronic variants |
| Method | Disease-specific NGS Panel for TP63 full gene sequencing | Whole Exome Capture + NGS (non-targeted) |
| Turnaround Time | 3 to 4 Weeks | 6–8 Weeks |
| Price | 2800 AED | 4500–6000 AED |
Physician Insight & Safety Protocol
Clinical Note from Dr. PRABHAKAR REDDY (DHA: 61713011): A positive TP63 result confirms a molecular diagnosis, but the full clinical picture must be correlated with the patient's physical findings and family history. I advise that no irreversible clinical decisions be made without multidisciplinary consultation. Genetic results are lifelong; empathy and ongoing support are vital for individuals and families managing these syndromic conditions.
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. If you are on any therapy for congenital anomalies or endocrine management, abrupt cessation can cause serious harm.
Safety & Exclusion Criteria
- Exclusion: Patients unable to provide a blood or DNA sample; individuals without a documented clinical indication or genetic counseling referral from a DHA-licensed physician.
- Exclusion: Test is not intended for prenatal diagnosis of acute limb‑mammary syndrome without prior multi‑disciplinary fetal assessment.
- Emergency Red Flags: If the patient presents with life‑threatening respiratory distress, severe feeding difficulties, or cyanosis linked to associated congenital anomalies, immediate emergency hospitalization is required before genetic testing.
Pre-Test Requirements
A detailed clinical history of the patient must be provided. A genetic counseling session to draw a pedigree chart of family members affected by TP63‑related conditions is mandatory before sample collection. For patients on anticoagulants or with bleeding disorders, contact our phlebotomy team for special handling.
Patient FAQ & Clinical Guidance
1. What does a TP63 NGS test detect and how long does it take?
The test sequences the entire coding region of the TP63 gene to identify disease‑causing mutations responsible for limb‑mammary syndrome, with final results typically delivered within 3 to 4 weeks.
يكشف الاختبار عن الطفرات المسببة لمتلازمة الطرف والثدي عبر تحليل جين TP63، وتصدر النتائج خلال 3 إلى 4 أسابيع.
2. Is home sample collection available across the UAE?
Yes, our ISO‑certified cold‑chain home collection and VIP mobile phlebotomy service operates daily from 8 AM to 11 PM, covering Dubai, Abu Dhabi, and all Northern Emirates.
نعم، تتوفر خدمة جمع العينات المنزلية المعتمدة ISO مع سلسلة تبريد من الساعة 8 صباحاً حتى 11 مساءً في جميع الإمارات.
3. Will my insurance cover the TP63, and how do I verify?
Direct billing eligibility is verified instantly via WhatsApp at +971 54 548 8731; our team cross‑checks your policy for genetic DHA‑mandated coverage before the draw.
يمكن التحقق من تغطية التأمين مباشرة عبر واتساب على الرقم +971 54 548 8731، حيث يتحقق فريقنا من وثيقتك وفق متطلبات هيئة الصحة بدبي.
Regulatory Compliance
- Compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87) on Genetic Testing Consent and Data Confidentiality.
- CDS Law 2026: Special protections for minors; genetic testing of minors requires parent/guardian consent and counseling.
- UAE PDPL (Personal Data Protection Law) – all patient data encrypted and stored under sovereign cloud.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – quality management system for medical laboratories.
- DHA Facility License: 9834453 | Laboratory operated under MOHAP standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians